
RlmN methylates tRNAChimeraUUG both in vivo and in vitro. (A) The sequence and secondary structure of the scaffold tRNA is shown together with a representative section of its HPLC chromatogram (D and Ψ modifications elute at early times and are not included in the figure). (B) The tRNAChimeraUUG sequence (red nucleotides indicate the ASL from tRNAGlncmnm5s2UUG) is shown together with a section of the corresponding chromatogram. (C) Synthesis in vivo of m2A on tRNAChimeraUUG (left panel) is prevented by mutation A37C (middle panel) or by the expression of the wild-type tRNAChimeraUUG in ΔrlmN cells (right panel). (D) In vitro methylation of tRNAChimeraUUG purified from ΔrlmN cells is carried out by in vitro-reconstituted RlmN in a SAM-dependent manner (red lines). Reconstituted RlmN does not work on in vitro synthesized tRNAGlnUUG (black lines). Solid and discontinuous lines indicate that the modification reactions were performed in the presence and absence of SAM, respectively. Absorbance was monitored at 260 nm. (mAU) Absorbance units ×10−3.










